Role of Lipid Profile in the Assessment of Nonalcoholic Steatohepatitis in Prediabetic and Diabetic Patients with Nonalcoholic Fatty Liver Disease
Explore this paper's citation graph
Summary
This dissertation aims to provide a history of biochemistry in India and investigates the role of phosphorous and its role in the immune system.
- Type
- article
- Published
- 2017-08-01
- Cited by
- 0
- References
- 19
- OpenAlex
- https://openalex.org/W2799489097
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:67796968
Keywords
Nonalcoholic fatty liver disease, Nonalcoholic steatohepatitis, Medicine, Internal medicine, Diabetes mellitus
References
- Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.
- Role of Insulin Resistance and Diabetes in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease
- Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
- Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.
- From the metabolic syndrome to NAFLD or vice versa?
- Spillover of dietary fatty acids and use of serum nonesterified fatty acids for the synthesis of VLDL-triacylglycerol under two different feeding regimens.
- Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients
- Overproduction of large VLDL particles is driven by increased liver fat content in man
- Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
- Fatty liver disease: the hepatic manifestation of metabolic syndrome
- Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- Metabolic syndrome and risk factors for non-alcoholic fatty liver disease.
- Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of NAFLD and NASH
- Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography
- Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.
- Relationship of Mallory bodies to intermediate filaments in hepatocytes. A scanning electron microscopy study.
- Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
- Fatty Liver Is Independently Associated With Alterations in Circulating HDL2 and HDL3 Subfractions
- Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients
Cited by
No citing papers recorded for this paper.
Related papers
- Aldafermin quantitatively improves inflammation in a 24-week clinical trial in patients with nonalcoholic steatohepatitis
- Correction of endotoxemia in patients with nonalcoholic steatohepatitis
- Vitamin E Improves Nonalcoholic Steatohepatitis
- 594 Antioxidant vitamin E prevents the development of nonalcoholic steatohepatitis (NASH) in rats
- Prof Jörn Schattenberg sheds light on key treatment and diagnostic approaches to nonalcoholic steatohepatitis (NASH)
- The Effects Of Proton Pump İnhibitors For Dispeptic Complaints In Patients With Nonalcoholic Steatohepatitis
- Nonalcoholic steatohepatitis in nonobese patients: Not so different after all
- Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic Steatofibrosis.